Scale, Automation and Moats in Diagnostics

Zurück gehen
Cover

RBC BlueBay’s Ben Yeoh examines how operational scale underpins competitive advantage in a flagship U.S. diagnostics lab 

  • Processing over 100,000 samples daily, automation lowers error rates and raises marginal profitability once fixed costs are absorbed.

  • Workflow design enables more tests per sample, driving revenue intensity without proportional cost growth.

  • Culture and technician retention remain decisive in a 24/7, high-skill environment where automation complements—not replaces—lab staff.

Is the moat technological—or organisational? The full note dissects the operating model.

Um diesen Artikel zu lesen, benötigen Sie ein Abonnement für Investment Officer. Falls Sie noch kein Abonnement haben, klicken Sie auf 'Abonnieren', um die verschiedenen Abonnementoptionen anzuzeigen.